date/time interval
- November 25, 2024 - October 31, 2029
Defining the oncogenic potential and therapeutic dependencies of PDAC-associated KRAS variants
Grant
Overview
awarded by
administered by
sponsor award ID
- 1 R01 CA290616-01A1
Affiliation
contributor
- Bernardo, Sara Key Personnel 2024 - 2029
- Chandwani, Rohit Principal Investigator 2024 - 2029
- Dow, Lukas Edward Co-Principal Investigator 2024 - 2029
- Hissong, Erika Co-Investigator 2024 - 2029
- Parsons, Marie Key Personnel 2024 - 2029